Valuation: Almirall, S.A.

Market Cap 2.25B 2.55B 2.13B 1.93B 3.62B 244B 3.65B 25.51B 9.83B 125B 9.56B 9.35B 402B P/E 2026 *
26.6x
P/E 2027 * 19.1x
Enterprise Value 2.15B 2.44B 2.04B 1.85B 3.46B 234B 3.49B 24.42B 9.41B 119B 9.15B 8.95B 384B EV / Sales 2026 *
1.75x
EV / Sales 2027 * 1.5x
Free-Float
35.93%
Yield 2026 *
1.96%
Yield 2027 * 2.04%
1 day-2.27%
1 week-1.90%
3 months-8.99%
6 months-14.71%
Current year-19.63%
1 week 10.3
Extreme 10.3
10.64
1 month 10.02
Extreme 10.02
10.82
Current year 10.02
Extreme 10.02
13.98
1 year 10.02
Extreme 10.02
13.98
3 years 7.85
Extreme 7.85
13.98
5 years 7.16
Extreme 7.16
13.98
10 years 7.16
Extreme 7.16
18.5
Manager TitleAgeSince
Chief Executive Officer - 02/11/2022
Director of Finance/CFO 53 31/08/2025
Chief Tech/Sci/R&D Officer - 07/07/2021
Director TitleAgeSince
Director/Board Member - 01/01/2014
Director/Board Member - 01/01/2016
Chairman - 06/05/2022
Date Insider Type Main position Quantity % Market Cap. Importance
23/06/23 Buy

Executive/Senior Manager

3,000 0.0017%
22/06/23 Buy 4,340 0.0024%
22/06/23 Buy

Executive/Senior Manager

5,000 0.0028%
Change 5-day change 1-year change 3-year change Capi.($)
-2.27%-1.90%-8.83%+7.28% 2.61B
-0.01%+1.24%+63.06%+120.55% 1,056B
-1.61%-0.60%+47.32%+71.79% 655B
-1.12%-0.72%+17.98%+76.63% 471B
-1.72%-4.06%+36.39%+39.47% 342B
-0.40%+3.83%+22.08%+28.82% 277B
-0.51%-1.93%+12.09%+11.94% 257B
+1.32%+3.27%+54.63%+57.63% 226B
-0.61%-0.91%+34.33%+101.87% 189B
-0.24%-2.76%-28.41%-60.92% 170B
Average -0.40%-0.11%+25.06%+45.51% 364.55B
Weighted average by Cap. -0.05%+0.41%+38.88%+70.48%

Financials

2026 *2027 *
Net sales 1.23B 1.39B 1.16B 1.05B 1.98B 134B 1.99B 13.94B 5.37B 68.18B 5.22B 5.11B 219B 1.35B 1.53B 1.28B 1.16B 2.17B 147B 2.19B 15.33B 5.91B 75B 5.75B 5.62B 241B
Net income 82.4M 93.37M 77.96M 70.7M 133M 8.96B 134M 935M 360M 4.57B 351M 343M 14.72B 115M 130M 109M 98.49M 185M 12.48B 186M 1.3B 502M 6.37B 488M 478M 20.51B
Net Debt -96.28M -109M -91.09M -82.61M -155M -10.47B -156M -1.09B -421M -5.35B -410M -401M -17.2B -227M -257M -215M -195M -365M -24.69B -369M -2.58B -993M -12.61B -966M -945M -40.57B
Logo Almirall, S.A.
Almirall SA is a Spain-based company principally engaged in the pharmaceuticals manufacture. The Company focuses on development and marketing of drugs applied in various therapeutic areas, such as nervous system, gastrointestinal, dermatological, respiratory system, antiinfectives, as well as antineoplastic and immunomodulating agents. The Company's activities are divided into four business segments: Own network, which focuses on the commercialization of pharmaceuticals through own brand names; Licenses, which sells product rights to third parties; Research and development (R&D), which is responsible for the creation of drug candidates, as well as Dermatology, which includes sale of dermatological medicines in the United States. The Company operates through numerous subsidiaries in Europe, the Americas, Africa, Asia and Australia.
Employees
2,097
Date Price Change Volume
29/09/26 €10.32 -2.27% 74,190
28/09/26 €10.56 +0.96% 78,169
25/09/26 €10.46 -0.38% 264,535
24/09/26 €10.50 +0.96% 70,671
23/09/26 €10.40 -1.14% 63,836
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
10.32EUR
Average target price
14.32EUR
Spread / Average Target
+38.81%

Quarterly revenue - Rate of surprise